H

Harriet M. Kluger

Yale Cancer Center

ORCID: 0000-0002-4932-9873

Publishes on Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Immunotherapy and Immune Responses. 837 papers and 32.1k citations.

PubIndex Score98Top 2%How it's scored

837Publications

32.1kTotal Citations

First publication: 2003First senior author: 1989

Cancer Immunotherapy and Biomarkers CAR-T cell therapy research Immunotherapy and Immune Responses Melanoma and MAPK Pathways Cutaneous Melanoma Detection and Management

Top publicationsby citations

Nivolumab plus Ipilimumab in Advanced Melanoma

Jedd D. Wolchok, Mario Sznol, Christine E. Horak et al.|New England Journal of Medicine|2013

Cited by 4.2k

Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab

Suzanne L. Topalian, F. Stephen Hodi, Mario Sznol et al.|Journal of Clinical Oncology|2014

Cited by 2.2k

Survival, Durable Response, and Long-Term Safety in Patients With Previously Treated Advanced Renal Cell Carcinoma Receiving Nivolumab

David F. McDermott, Michael B. Atkins, Charles G. Drake et al.|Journal of Clinical Oncology|2015

Cited by 443

Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab

Suzanne L. Topalian, F. Stephen Hodi, Mario Sznol et al.|Journal of Clinical Oncology|2023

Cited by 231

Phosphatidylinositol-3-Kinase as a Therapeutic Target in Melanoma

Saadia A. Aziz, Harriet M. Kluger|Clinical Cancer Research|2009

Cited by 72